Research Articles | Page 15 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Impact of HLA alloimmunization on clinical outcomes of severe aplastic anemia treated with immunosuppressive therapy Jun 2025 Blood Advances Aplastic Anemia
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors Feb 2021 Blood Advances Myelodysplastic Syndromes (MDS)
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Nov 2020 Blood Advances Myelodysplastic Syndromes (MDS)
Modified Delphi Panel Consensus Recommendations for Management of Severe Aplastic Anemia Apr 2024 Blood Advances Aplastic Anemia
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates Feb 2025 Blood Advances Aplastic Anemia
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study Dec 2023 Blood Advances Aplastic Anemia
ESCALATing care? Eltrombopag in pediatric aplastic anemia Aug 2025 Blood Advances Aplastic Anemia
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse Jul 2020 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice. Sep 2025 Blood Advances Aplastic Anemia